查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032916

製藥品管軟體市場規模、佔有率、趨勢和預測：按解決方案類型、部署模式、公司規模、最終用戶和地區分類，2026-2034 年

Pharmaceutical Quality Management Software Market Size, Share, Trends and Forecast by Solution Type, Deployment Model, Enterprise Size, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3個工作天內

價格

2025年全球醫藥品管軟體市場規模為15億美元。展望未來，IMARC Group預測，該市場將在2026年至2034年間以8.55%的複合年成長率成長，到2034年達到31億美元。目前，北美市場佔據主導地位，預計2025年將佔42.5%的市場。推動該市場成長的因素包括日益成長的監管合規要求、藥品生產日益複雜的過程以及對營運效率的需求。各組織正在採用數位化解決方案來簡化品質流程、最大限度地減少人為干預，並確保全球營運的一致性。除了縮短產品上市時間的需求外，對產品安全和風險管理的日益關注也進一步推動了醫藥品管軟體市場佔有率的成長。與人工智慧（AI）等新技術的整合也加速了數據分析和決策制定，從而加強了整體品質保證。

推動製藥品管軟體產業發展的主要動力是日益嚴格的監管合規需求。隨著製藥流程日趨複雜，企業面臨維護產品品質和安全的越來越大的壓力。監管機構要求嚴格遵守規程和文件記錄，迫使企業採用先進的數位化工具。品管軟體有助於簡化審核、文件管理並實現營運流程的標準化。這不僅能最大限度地降低違規風險，還能提高營運效率。因此，製藥公司正在加大對這些解決方案的投資，以保持競爭力並控制監管風險。

美國擁有成熟的製藥產業和嚴格的管理體制，是全球製藥品管軟體市場的領導者，佔89.80%的市場。為了符合FDA的要求和產業最佳實踐，各公司正日益推動數位化轉型。品管軟體有助於簡化操作流程、規格文件並促進快速決策。美國集中了大型製藥企業和技術創新企業，這也促進了此類軟體的快速發展和應用。隨著對生產效率、安全性和合規性的需求不斷成長，美國市場在製藥品管的創新和標準方面繼續保持主導地位。

醫藥品管軟體市場的發展趨勢：

擴大雲端解決方案的使用

由於其柔軟性，基於雲端的品管解決方案正日益普及。這使得製藥公司能夠在無需承擔大量前期成本的情況下，提高擴展效率、實現遠端存取和即時協作。 2024年7月，Antares Vision Group發布了“DIAMIND Sentry”，該解決方案能夠促進協作並無縫管理法規遵從性，幫助製藥公司有效應對日益增多的異常情況。這款基於雲端的軟體使製造商、批發商和分銷商能夠檢測並修正產品資料交換中的缺陷。根據一份產業報告顯示，41%的公司認為人工返工是一項主要挑戰，凸顯了現有系統的低效率。同時，31%的公司對資料交換錯誤表示擔憂，並強調了在DSCSA法規下產品可追溯性所面臨的挑戰。這一趨勢正顯著推動製藥品管軟體市場佔有率的擴張。

引入自動化以符合監管要求

隨著企業努力消除人工流程和人為錯誤，品管系統中合規流程的自動化變得日益重要。一項行業調查顯示，約74%的違規是由人為錯誤造成的。製藥公司可以透過自動化文件管理、審計追蹤和報告流程，確保符合FDA和其他全球標準。 2024年4月，全球領先的變革性智慧公司科睿唯安（Clarivate Plc）宣布收購生命科學公司Global QMS。 Global QMS提供基於雲端的解決方案，協助客戶實現監管報告和合規管理的自動化。這項收購將為製藥品管軟體市場帶來正面影響。

與人工智慧和機器學習的廣泛整合。

人工智慧 (AI) 和機器學習 (ML) 透過品質營運自動化、進階資料分析和預測性維護，正在提升品管系統。產業研究表明，80% 的製藥和生命科學專業人士在藥物研發中使用 AI，95% 的製藥公司正在積極投資 AI 技術。這些技術有助於及早發現趨勢和異常情況，從而實現快速糾正措施。 Veeva Systems 於 2024 年 4 月宣布推出的「Veeva AI 合作夥伴計畫」旨在為合作夥伴提供必要的最尖端科技和支持，以實現 Veeva Vault 應用和生成式人工智慧 (GenAI) 解決方案的無縫整合。這一趨勢在推動製藥品管軟體需求的成長方面發揮著重要作用。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球製藥品管軟體市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依解決方案類型分類

  • 糾正和預防措施 (CAPA) 管理
  • 審計管理
  • 文件管理
  • 變革管理
  • 培訓管理
  • 風險管理
  • 申訴管理
  • 監理與合規管理
  • 不合格項的處理
  • 供應品管
  • 檢查管理
  • 設備管理
  • 其他

第7章 市場區隔：依部署模式分類

  • 雲端
  • 基於網路的
  • 現場

第8章 市場區隔：依公司規模分類

  • 小型企業
  • 大公司

第9章 市場區隔：依最終用戶分類

  • 製藥、生命科學和生物技術公司
  • 受託研究機構
  • 其他

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章：促進、抑制與機遇

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • AssurX Inc.
    • ComplianceQuest
    • Dassault Systemes SE（Dassault Group）
    • ETQ LLC（Hexagon AB）
    • Ideagen
    • IQVIA Inc.
    • Mastercontrol Inc.
    • Qualio
    • Veeva Systems Inc.
Product Code: SR112026A7649

The global pharmaceutical quality management software market size was valued at USD 1.5 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 3.1 Billion by 2034, exhibiting a CAGR of 8.55% from 2026-2034. North America currently dominates the market, holding a market share of 42.5% in 2025. The market includes the increasing regulatory compliance needs, increased drug manufacturing complexity, and operational efficiency demands. Organizations are implementing digital solutions to simplify quality processes, minimize human intervention, and ensure global operations consistency. The demand for quicker time-to-market along with greater attention on product safety and risk management further fuel pharmaceutical quality management software market share. Integration with new technologies such as artificial intelligence (AI) also increases data analysis and decision-making, enhancing overall quality assurance.

A key force propelling the pharmaceutical quality management software industry is growing compliance with strict regulatory requirements. With growing complexity of pharmaceutical processes, companies are under increased pressure to maintain product quality and safety consistency. Regulatory agencies require rigorous adherence to protocols and paperwork, compelling companies to implement sophisticated digital tools. Quality management software facilitates streamlined audits, document control, and procedure standardization across operations. This not only minimizes the risk of non-compliance but also improves the efficiency of operations. Pharmaceutical companies are, therefore, investing more in such solutions to remain competitive and manage regulatory threats.

The United States is a global leader with a share of 89.80% in the pharmaceutical quality management software market owing to its sophisticated pharmaceutical industry and stringent regulatory setup. Firms are increasingly going digital to stay in compliance with FDA mandates and industry best practices. Quality management software assists in streamlining operations, standardizing documentation, and facilitating quicker decision-making. The availability of major pharmaceutical firms and technology innovators in the U.S. also plays a role in their speedy development and usage. With the increasing demand for productivity, safety, and regulatory compliance, the U.S. market still leads in innovation and standards in pharmaceutical quality management.

PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET TRENDS:

Increase in Usage of Cloud-Based Solutions

Cloud-based quality management solutions are gaining popularity due to their flexibility, allowing pharmaceutical businesses to scale efficiently, offer remote access, and improve real-time collaboration without incurring significant upfront costs. In July 2024, Antares Vision Group released DIAMIND Sentry, a solution that will enable pharma businesses to effectively deal with the significant increase in exceptions by facilitating collaboration and managing regulatory compliance seamlessly. The cloud-based software enables manufacturers, wholesalers, and dispensers to detect and correct product data exchange faults. An industry report found that 41% of companies identified manual rework as a key issue, highlighting inefficiencies in current systems, while 31% expressed concerns over data exchange errors, underscoring challenges with product traceability under DSCSA regulations. This trend is largely adding to the pharmaceutical quality management software market share.

Implementation of Regulatory Compliance Automation

Automation of regulatory compliance within the quality management system is becoming more crucial as firms seek to eliminate manual effort and human mistake. According to an industry study, nearly 74% of compliance failures are attributed to human errors. Pharmaceutical companies can ensure compliance with the FDA and other global standards by automating document control, audit trails, and reporting. In April 2024, Clarivate Plc, a global leader in transformative intelligence, revealed that it had acquired Global QMS, Inc., or Global Q, a life sciences solutions provider of cloud-based offerings that allow clients to automate regulatory reporting and compliance management. This trend is contributing to the pharmaceutical quality management software market outlook.

Widespread Integration with AI and Machine Learning

Artificial intelligence (AI) and machine learning (ML) enhance quality management systems through automated quality operations, enhanced data analysis, and predictive maintenance. It was found through an industry survey that 80% of pharmaceutical and life sciences professionals utilize AI for drug discovery, and 95% of pharmaceutical firms are proactively investing in AI capabilities. The technologies aid early trend and anomaly detection, enabling prompt corrective action. Veeva Systems Veeva AI Partner Program announced in April 2024 aims to equip partners with the cutting-edge technology and support required to integrate Veeva Vault applications with generative AI (GenAI) solutions seamlessly. The trend plays a major role in enhancing the demand of the pharmaceutical quality management software market.

PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE INDUSTRY SEGMENTATION:

Analysis by Solution Type:

  • Corrective Action Preventive Action (CAPA) Management
  • Audit Management
  • Document Management
  • Change Management
  • Training Management
  • Risk Management
  • Complaints Management
  • Regulatory and Compliance Management
  • Non-Conformances Handling
  • Supplier Quality Management
  • Inspection Management
  • Equipment Management
  • Others

Regulatory and compliance management holds a dominant 18.7% share due to the industry's highly regulated nature. Pharmaceutical companies must adhere to strict guidelines from bodies like the FDA, EMA, and WHO to ensure product safety, efficacy, and quality. Non-compliance can lead to costly recalls, legal penalties, and reputational damage. As a result, there is a growing demand for software that can streamline compliance processes, manage documentation, track audits, and ensure traceability. These tools help companies stay updated with evolving regulations and maintain accurate records for inspections. The increasing complexity of global regulatory frameworks drives the need for automated, centralized solutions, making regulatory and compliance management a key driver of market growth.

Analysis by Deployment Model:

  • On-Cloud
  • Web-Based
  • On-Premises

On Cloud solutions account for the majority share of 47.3% in the pharmaceutical quality management software market due to their flexibility, scalability, and cost-efficiency. These platforms allow organizations to access real-time data from any location, streamlining collaboration across global teams. Unlike traditional on-premise systems, cloud-based solutions require minimal upfront investment and reduce IT infrastructure costs. They also offer faster deployment, automatic updates, and better integration with other enterprise systems. Additionally, cloud platforms enhance data security and compliance through advanced encryption and regular backups, critical for meeting stringent pharmaceutical regulations. With the industry's increasing focus on digital transformation and remote operations, especially post-pandemic, cloud and web-based solutions have become the preferred choice for ensuring efficient, compliant quality management.

Analysis by Enterprise Size:

  • Small and Medium-sized Enterprises
  • Large Enterprises

Large enterprises dominate the pharmaceutical quality management software market, holding a 64.6% share due to their extensive operational scale, stringent compliance requirements, and higher investment capacity. These organizations often operate across multiple regions, requiring robust, standardized quality management systems to ensure regulatory adherence, risk mitigation, and process efficiency. Their substantial budgets also enable them to adopt advanced software solutions with features like audit management, CAPA, document control, and real-time analytics. Additionally, large enterprises are more likely to pursue digital transformation strategies, prioritizing automation and integration across departments. As regulatory frameworks become more complex, these companies rely heavily on comprehensive software solutions to maintain quality standards and product safety, driving their dominant market share.

Analysis by End User:

  • Pharmaceutical, Life Sciences, and Biotechnology Companies
  • Contract Research Organizations
  • Others

Based on the pharmaceutical quality management software market forecast, the pharmaceutical, life science, and biotechnology firms are the largest shareholders with 55.0% in the pharmaceutical quality management software market, as their demand for regulatory requirements, accuracy, and product safety is high. These sectors follow stringent regulations that call for strict documentation, quality control, and process standardization. With drug development, manufacturing, and clinical trials becoming increasingly sophisticated, these organizations increasingly turn to digital quality systems to oversee risk, validate data integrity, and ensure consistency of operations. Their requirement to adhere to changing global regulatory guidelines, enhance operational effectiveness, and speed up time-to-market fuels considerable investment in cutting-edge quality management solutions. Such consistent demand makes them leaders in adopting and market-leaders in the broader marketplace.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America dominates the pharmaceutical quality management software market with 42.5%, mainly because of its stringent regulation and well-developed technological base. The U.S. Food and Drug Administration (FDA) imposes stringent compliance norms, leading pharmaceutical manufacturers to implement advanced quality management systems to meet compliance and retain product purity. The region's high focus on research and development, along with high investments in healthcare, fuel demand for effective quality management solutions. In addition, the existence of leading pharma companies and a strong healthcare ecosystem also supports the expedited adoption of advanced software tools. The incorporation of complex technologies like artificial intelligence and cloud computing also further increases operational effectiveness as these allow better management of data, further cementing North America's leadership position in the market.

KEY REGIONAL TAKEAWAYS:

UNITED STATES PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET ANALYSIS

The United States pharmaceutical quality management software market is primarily driven by increased FDA oversight and stricter enforcement of current Good Manufacturing Practices (cGMP). In line with this, the rising volume of decentralized and multi-site clinical trials necessitating centralized quality oversight tools is impelling the market. Similarly, the growing reliance on Contract Development and Manufacturing Organizations (CDMOs) is encouraging the use of standardized, cloud-based QMS to manage outsourced quality functions. The expanding role of real-world evidence in drug development, driving demand for data-integrity-compliant quality systems, is fostering market expansion. Furthermore, the rapid integration of AI into quality monitoring for predictive analytics and error detection is enhancing operational efficiency. Additionally, the ongoing digitization of supply chains, promoting interoperability among quality platforms across stakeholders, is propelling market growth. Moreover, increasing cybersecurity risks tied to protected health information (PHI) are pushing the adoption of secure, validated QMS solutions. According to an industry report, ransomware attacks targeting the U.S. healthcare sector increased by 128% in 2023 compared to 2022. In 2024, 389 healthcare institutions across the country were forced to shut down or experienced delays in medical procedures as a result of these attacks.

EUROPE PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET ANALYSIS

The market in Europe is experiencing growth due to increasing regulatory alignment under the European Medicines Agency and stricter compliance with Annex 11 for computerized systems. In accordance with this, enforcement of the Falsified Medicines Directive, accelerating the adoption of digital quality platforms to enhance serialization and traceability, is impelling the market. Similarly, pharmaceutical manufacturing expansion in Eastern Europe is driving investment in standardized and scalable QMS infrastructure. The rise in biotech firms and ATMP developers, augmenting demand for cloud-enabled, configurable quality management tools, is propelling market growth. According to industry analysis, in 2023, European biotech firms raised about USD 11.5 Billion in venture capital, representing 7% of global biotech investment. Public funding also increased, supported by initiatives such as France's EUR 7 Billion innovation fund, Germany's Zukunftsfonds, and the European Investment Bank (EIB). Furthermore, compliance with shifting ISO standards and pharmacovigilance protocols, prompting system upgrades across manufacturing sites, is strengthening market demand. The rapid integration of digital twins and simulation tools in pharmaceutical production, supporting predictive quality control measures, is stimulating pharmaceutical quality management software market growth. Besides this, an increase in Horizon Europe funding for public-private research and development (R&D) partnerships is encouraging innovation in compliance technology.

ASIA PACIFIC PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET ANALYSIS

The Asia Pacific pharmaceutical quality management software market is majorly propelled by the rapid growth of pharmaceutical manufacturing hubs in India, China, and South Korea. India is the third-largest producer of pharmaceuticals by volume globally, exporting to nearly 200 countries and territories. With a strong domestic manufacturing base and an annual growth rate of 10-12%, the industry is projected to reach USD 100 Billion by 2025. In addition to this, the increasing adoption of electronic batch records and digital documentation is enhancing traceability and compliance. Similarly, government-led initiatives like India's Production Linked Incentive (PLI) scheme incentivize quality infrastructure investments across pharma operations, impelling the market. Furthermore, the rising presence of global CROs and CMOs in the region, promoting scalable quality systems capable of multi-site integration, is fostering market expansion. Moreover, the rise in biosimilar and generic drug development is amplifying the complexity of regulatory oversight, driving heightened software adoption. Apart from this, continual advancements in mobile-accessible QMS interfaces are enabling seamless real-time collaboration among geographically dispersed teams, contributing to operational agility and market expansion.

LATIN AMERICA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET ANALYSIS

The Latin America pharmaceutical quality management software market is gaining momentum due to increasing regulatory harmonization efforts driven by regional agencies such as ANVISA and COFEPRIS. Similarly, the expansion of domestic pharmaceutical production capabilities, particularly in Brazil and Mexico, is encouraging the implementation of structured digital quality systems. The growing participation in global clinical trials necessitates compliance with international GxP standards through integrated quality platforms, which is fostering market expansion. Additionally, rising investment in healthtech and digital infrastructure is fostering the adoption of cloud-based QMS solutions tailored for multilingual and region-specific compliance requirements. As such, Brazilian healthtech Carecode raised a USD 4.3 Million pre-seed round led by Andreessen Horowitz and QED. Its AI WhatsApp agent helps hospitals and clinics manage patient journeys, cutting operational costs by handling scheduling, follow-ups, and payment reminders via audio and text.

MIDDLE EAST AND AFRICA PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET ANALYSIS

The Middle East and Africa market is progressing due to increased government investment in pharmaceutical manufacturing under national health strategies, particularly in Saudi Arabia, Egypt, and South Africa. Accordingly, Saudi Arabia currently has around 206 pharmaceutical and medical device factories with SR 10 Billion (USD 2.6 Billion) in investments. The pharmaceutical market grew 25% from 2019-2023, with localization efforts reducing import reliance and boosting domestic production, including advanced medical devices and vaccines. Furthermore, the heightened adoption of international quality certifications, such as WHO GMP and ISO 9001, is driving demand for digital QMS tools. Additionally, the region's expanding clinical research landscape, promoting the need for standardized quality documentation systems, is strengthening market demand. Moreover, growing interest in pharmaceutical exports is also pushing companies to adopt compliant, audit-ready platforms to meet stringent global regulatory expectations.

COMPETITIVE LANDSCAPE:

The competitive scene is dominated by a mix of mature technology companies and niche life sciences vendors. Dominant companies are Veeva Systems, MasterControl, Dassault Systemes, IQVIA, and Sparta Systems (part of Honeywell), all of which provide customized solutions to meet regulatory compliance, process automation, and data integrity requirements. The companies compete on cloud-based platforms, integration, and domain-specific features. It is also influenced by mergers and acquisitions, strategic alliances, and ongoing innovation to improve product quality and global presence. With increasing regulatory needs and an escalating need for effective management of quality, competition increases, and firms are compelled to provide more advanced and easy-to-use software applications.

The report provides a comprehensive analysis of the competitive landscape in the pharmaceutical quality management software market with detailed profiles of all major companies, including:

  • AssurX Inc.
  • ComplianceQuest
  • Dassault Systemes SE (Dassault Group)
  • ETQ LLC (Hexagon AB)
  • Ideagen
  • IQVIA Inc.
  • Mastercontrol Inc.
  • Qualio
  • Veeva Systems Inc

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pharmaceutical Quality Management Software Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Solution Type

  • 6.1 Corrective Action Preventive Action (CAPA) Management
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Audit Management
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Document Management
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Change Management
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Training Management
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Risk Management
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Complaints Management
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Regulatory and Compliance Management
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast
  • 6.9 Non-Conformances Handling
    • 6.9.1 Market Trends
    • 6.9.2 Market Forecast
  • 6.10 Supplier Quality Management
    • 6.10.1 Market Trends
    • 6.10.2 Market Forecast
  • 6.11 Inspection Management
    • 6.11.1 Market Trends
    • 6.11.2 Market Forecast
  • 6.12 Equipment Management
    • 6.12.1 Market Trends
    • 6.12.2 Market Forecast
  • 6.13 Others
    • 6.13.1 Market Trends
    • 6.13.2 Market Forecast

7 Market Breakup by Deployment Model

  • 7.1 On-Cloud
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Web-Based
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 On-Premises
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Enterprise Size

  • 8.1 Small and Medium-sized Enterprises
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Large Enterprise
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Pharmaceutical, Life Sciences, and Biotechnology Companies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Contract Research Organizations
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 AssurX Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 ComplianceQuest
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Dassault Systemes SE (Dassault Group)
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 ETQ LLC (Hexagon AB)
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Ideagen
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 IQVIA Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Mastercontrol Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Qualio
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Veeva Systems Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Pharmaceutical Quality Management Software Market: Major Drivers and Challenges
  • Figure 2: Global: Pharmaceutical Quality Management Software Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Pharmaceutical Quality Management Software Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Pharmaceutical Quality Management Software Market: Breakup by Solution Type (in %), 2025
  • Figure 5: Global: Pharmaceutical Quality Management Software Market: Breakup by Deployment Model (in %), 2025
  • Figure 6: Global: Pharmaceutical Quality Management Software Market: Breakup by Enterprise Size (in %), 2025
  • Figure 7: Global: Pharmaceutical Quality Management Software Market: Breakup by End User (in %), 2025
  • Figure 8: Global: Pharmaceutical Quality Management Software Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Pharmaceutical Quality Management Software (Corrective Action Preventive Action (CAPA) Management) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Pharmaceutical Quality Management Software (Corrective Action Preventive Action (CAPA) Management) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Pharmaceutical Quality Management Software (Audit Management) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Pharmaceutical Quality Management Software (Audit Management) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Pharmaceutical Quality Management Software (Document Management) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Pharmaceutical Quality Management Software (Document Management) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Pharmaceutical Quality Management Software (Change Management) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Pharmaceutical Quality Management Software (Change Management) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Pharmaceutical Quality Management Software (Training Management) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Pharmaceutical Quality Management Software (Training Management) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Pharmaceutical Quality Management Software (Risk Management) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Pharmaceutical Quality Management Software (Risk Management) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Pharmaceutical Quality Management Software (Complaints Management) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Pharmaceutical Quality Management Software (Complaints Management) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Pharmaceutical Quality Management Software (Regulatory and Compliance Management) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Pharmaceutical Quality Management Software (Regulatory and Compliance Management) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Pharmaceutical Quality Management Software (Non-Conformances Handling) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Pharmaceutical Quality Management Software (Non-Conformances Handling) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Pharmaceutical Quality Management Software (Supplier Quality Management) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Pharmaceutical Quality Management Software (Supplier Quality Management) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Pharmaceutical Quality Management Software (Inspection Management) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Pharmaceutical Quality Management Software (Inspection Management) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Pharmaceutical Quality Management Software (Equipment Management) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Pharmaceutical Quality Management Software (Equipment Management) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Pharmaceutical Quality Management Software (Other Solution Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Pharmaceutical Quality Management Software (Other Solution Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Global: Pharmaceutical Quality Management Software (On-Cloud) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Global: Pharmaceutical Quality Management Software (On-Cloud) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Global: Pharmaceutical Quality Management Software (Web-Based) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Global: Pharmaceutical Quality Management Software (Web-Based) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Global: Pharmaceutical Quality Management Software (On-Premises) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Global: Pharmaceutical Quality Management Software (On-Premises) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Global: Pharmaceutical Quality Management Software (Small and Medium-sized Enterprises) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Global: Pharmaceutical Quality Management Software (Small and Medium-sized Enterprises) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Global: Pharmaceutical Quality Management Software (Large Enterprise) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Global: Pharmaceutical Quality Management Software (Large Enterprise) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Global: Pharmaceutical Quality Management Software (Pharmaceutical, Life Sciences, and Biotechnology Companies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Global: Pharmaceutical Quality Management Software (Pharmaceutical, Life Sciences, and Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Global: Pharmaceutical Quality Management Software (Contract Research Organizations) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Global: Pharmaceutical Quality Management Software (Contract Research Organizations) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Global: Pharmaceutical Quality Management Software (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Global: Pharmaceutical Quality Management Software (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: North America: Pharmaceutical Quality Management Software Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: North America: Pharmaceutical Quality Management Software Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: United States: Pharmaceutical Quality Management Software Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: United States: Pharmaceutical Quality Management Software Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Canada: Pharmaceutical Quality Management Software Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Canada: Pharmaceutical Quality Management Software Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Asia-Pacific: Pharmaceutical Quality Management Software Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Asia-Pacific: Pharmaceutical Quality Management Software Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: China: Pharmaceutical Quality Management Software Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: China: Pharmaceutical Quality Management Software Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Japan: Pharmaceutical Quality Management Software Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Japan: Pharmaceutical Quality Management Software Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: India: Pharmaceutical Quality Management Software Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: India: Pharmaceutical Quality Management Software Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: South Korea: Pharmaceutical Quality Management Software Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: South Korea: Pharmaceutical Quality Management Software Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Australia: Pharmaceutical Quality Management Software Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Australia: Pharmaceutical Quality Management Software Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Indonesia: Pharmaceutical Quality Management Software Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Indonesia: Pharmaceutical Quality Management Software Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Others: Pharmaceutical Quality Management Software Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Others: Pharmaceutical Quality Management Software Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Europe: Pharmaceutical Quality Management Software Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Europe: Pharmaceutical Quality Management Software Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Germany: Pharmaceutical Quality Management Software Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Germany: Pharmaceutical Quality Management Software Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: France: Pharmaceutical Quality Management Software Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: France: Pharmaceutical Quality Management Software Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: United Kingdom: Pharmaceutical Quality Management Software Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: United Kingdom: Pharmaceutical Quality Management Software Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Italy: Pharmaceutical Quality Management Software Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 82: Italy: Pharmaceutical Quality Management Software Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 83: Spain: Pharmaceutical Quality Management Software Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 84: Spain: Pharmaceutical Quality Management Software Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 85: Russia: Pharmaceutical Quality Management Software Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 86: Russia: Pharmaceutical Quality Management Software Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 87: Others: Pharmaceutical Quality Management Software Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 88: Others: Pharmaceutical Quality Management Software Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 89: Latin America: Pharmaceutical Quality Management Software Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 90: Latin America: Pharmaceutical Quality Management Software Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 91: Brazil: Pharmaceutical Quality Management Software Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 92: Brazil: Pharmaceutical Quality Management Software Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 93: Mexico: Pharmaceutical Quality Management Software Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 94: Mexico: Pharmaceutical Quality Management Software Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 95: Others: Pharmaceutical Quality Management Software Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 96: Others: Pharmaceutical Quality Management Software Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 97: Middle East and Africa: Pharmaceutical Quality Management Software Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 98: Middle East and Africa: Pharmaceutical Quality Management Software Market: Breakup by Country (in %), 2025
  • Figure 99: Middle East and Africa: Pharmaceutical Quality Management Software Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 100: Global: Pharmaceutical Quality Management Software Industry: Drivers, Restraints, and Opportunities
  • Figure 101: Global: Pharmaceutical Quality Management Software Industry: Value Chain Analysis
  • Figure 102: Global: Pharmaceutical Quality Management Software Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pharmaceutical Quality Management Software Market: Key Industry Highlights, 2025 & 2034
  • Table 2: Global: Pharmaceutical Quality Management Software Market Forecast: Breakup by Solution Type (in Million USD), 2026-2034
  • Table 3: Global: Pharmaceutical Quality Management Software Market Forecast: Breakup by Deployment Model (in Million USD), 2026-2034
  • Table 4: Global: Pharmaceutical Quality Management Software Market Forecast: Breakup by Enterprise Size (in Million USD), 2026-2034
  • Table 5: Global: Pharmaceutical Quality Management Software Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 6: Global: Pharmaceutical Quality Management Software Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Pharmaceutical Quality Management Software Market: Competitive Structure
  • Table 8: Global: Pharmaceutical Quality Management Software Market: Key Players